The FDA’s diagnostics chief, who led through Covid, has retired
Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency.
Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency.
A study in The American Journal of Clinical Nutrition reveals that higher dietary protein intake, especially plant protein, in middle adulthood significantly increases the likelihood
Marik is an engineer, advocate, entrepreneur, and investor who has worked across “counter culture” industries. He founded the first incubator focused on psychedelic startups and
Amid a push to crack down on patent abuse by the pharmaceutical industry, a key U.S. lawmaker is urging six large drug companies to remove
Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024? We cover all that and
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in
Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation within health records software made by Epic, a move to
Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing
WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the CEOs of Johnson & Johnson and Merck related to an
Highlights: 72 patients treated at purpose-built facilities within Monash University, Melbourne, Australia. Topline results from the trial anticipated within current Q1 2024. FDA IND application